CHICAGO, Oct. 31, 2019 /PRNewswire/ -- Rising Medical Solutions executive, Rachel Fikes, has assumed a new, elevated position with the company as it looks to create further value for its two primary constituencies – its customers and its employee shareholders. Formerly the Vice President of Marketing and Director of the Workers'

SANTA MONICA, Calif., Oct. 31, 2019 /PRNewswire/ -- PatientPop, the leader in healthcare practice growth technology, today announced a

SEATTLE and VANCOUVER, British Columbia, Oct. 31, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its third quarter 201

LOS ANGELES, Oct. 31, 2019 /PRNewswire/ -- This November, Americans will see more moustaches walking the streets as Movember kicks-off its 12th annual campaign across the United States, returning with its month-long fundraiser challenging men and women to sign up on Movember.com and Grow, Move or Host to help raise funds and awarenes

WEST PALM BEACH, Fla., Oct. 31, 2019 /PRNewswire/ -- Internationally acclaimed Hispanic artist 'Charytin' invites the public to her next 'Charytour' event November 6th in West Palm Beach. Charytin is spreading her positive message about the importance of maintaining a healthy mind, body and spirit throug

LINKÖPING, Sweden, Oct. 31, 2019 /PRNewswire/ --  International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract for its ent

STOCKHOLM, Oct. 31, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the third quarter 2019. Revenue growth in the quarter was 2

MALMÖ, Sweden, Oct. 31, 2019 /PRNewswire/ --- Positive results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in highly sensitized kidney transplant patients were presented for the first time at the European Society of Organ Transplantation's (ESOT) Congress on September 17. Imlifidase enabled kidney

STOCKHOLM, Oct. 31, 2019 /PRNewswire/ -- On Thursday November 14, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q3 2019 interim report (which will have been published earlier on the 14th at 08.00 a.m. CET). The presentation will be

COPENHAGEN, Denmark, Oct. 30, 2019 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) announced today that it is raising its Outlook for 2019.  The improvement is due to better than expected sales of Envarsus XR® (tacrolimus extended-release tablets).